A simple method of quantifying chemotherapy-induced peripheral neuropathy using PainVision PS-2100®.
Motoaki SaitoSuguru OdajimaRyo YokomizoJyunya TabataYasushi IidaKazu UedaNozomu YanaiharaKyosuke YamadaAikou OkamotoPublished in: Asia-Pacific journal of clinical oncology (2019)
Our preliminary results suggest that peripheral neuropathy may be quantified using PV. As CIPN often lowers QOL, it needs to be appropriately evaluated. Future studies with a larger patient cohort and methodological refinements to improve accuracy are warranted.